HEADER HYDROLASE 08-SEP-16 5LU9 TITLE CRYSTAL STRUCTURE OF YVAD-CMK BOUND HUMAN LEGUMAIN (AEP) IN COMPLEX TITLE 2 WITH COMPOUND 11 COMPND MOL_ID: 1; COMPND 2 MOLECULE: AC-TYR-VAL-ALA-ASP-CHLOROMETHYLKETONE; COMPND 3 CHAIN: C; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: AC-YVAD-CHLOROMETHYLEKETONE INHIBITOR; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: LEGUMAIN; COMPND 8 CHAIN: A; COMPND 9 FRAGMENT: UNP RESIDUES 26-288; COMPND 10 SYNONYM: ASPARAGINYL ENDOPEPTIDASE,PROTEASE,CYSTEINE 1; COMPND 11 EC: 3.4.22.34; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 32630; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 7 ORGANISM_COMMON: HUMAN; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 GENE: LGMN, PRSC1; SOURCE 10 EXPRESSION_SYSTEM: LEISHMANIA TARENTOLAE; SOURCE 11 EXPRESSION_SYSTEM_TAXID: 5689 KEYWDS CYSTEINE PROTEASE, ALLOSTERIC INHIBITOR, ASPARAGINYL ENDOPEPTIDASE, KEYWDS 2 ALZHEIMER'S DISEASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR E.DALL,K.YE,H.BRANDSTETTER REVDAT 6 17-JAN-24 5LU9 1 REMARK REVDAT 5 15-NOV-23 5LU9 1 HETSYN LINK ATOM REVDAT 4 29-JUL-20 5LU9 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 13-JUN-18 5LU9 1 REMARK REVDAT 2 05-APR-17 5LU9 1 JRNL REVDAT 1 29-MAR-17 5LU9 0 JRNL AUTH Z.ZHANG,O.OBIANYO,E.DALL,Y.DU,H.FU,X.LIU,S.S.KANG,M.SONG, JRNL AUTH 2 S.P.YU,C.CABRELE,M.SCHUBERT,X.LI,J.Z.WANG,H.BRANDSTETTER, JRNL AUTH 3 K.YE JRNL TITL INHIBITION OF DELTA-SECRETASE IMPROVES COGNITIVE FUNCTIONS JRNL TITL 2 IN MOUSE MODELS OF ALZHEIMER'S DISEASE. JRNL REF NAT COMMUN V. 8 14740 2017 JRNL REFN ESSN 2041-1723 JRNL PMID 28345579 JRNL DOI 10.1038/NCOMMS14740 REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 13753 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.245 REMARK 3 R VALUE (WORKING SET) : 0.244 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 745 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.27 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.33 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1041 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.3000 REMARK 3 BIN FREE R VALUE SET COUNT : 59 REMARK 3 BIN FREE R VALUE : 0.3590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2150 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 70 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.37 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.23000 REMARK 3 B22 (A**2) : 0.23000 REMARK 3 B33 (A**2) : -0.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.398 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.260 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.186 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.473 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.923 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.898 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2265 ; 0.006 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2035 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3077 ; 1.080 ; 1.958 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4675 ; 0.723 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 263 ; 5.645 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 111 ;36.413 ;24.505 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 360 ;13.922 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ; 9.533 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 322 ; 0.057 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2567 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 544 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1065 ; 1.394 ; 3.811 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1065 ; 1.393 ; 3.811 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1323 ; 2.382 ; 5.705 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1324 ; 2.381 ; 5.707 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1199 ; 1.281 ; 4.069 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1200 ; 1.280 ; 4.070 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1744 ; 2.160 ; 6.023 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2624 ; 3.818 ;31.253 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2625 ; 3.818 ;31.263 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5LU9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1200001363. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.873 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16546 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 45.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.900 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.30 REMARK 200 R MERGE FOR SHELL (I) : 0.71000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4AWA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 0.2 M LITHIUM REMARK 280 SULFATE MONOHYDRATE, 25 % PEG 3350, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z+1/2 REMARK 290 4555 Y,-X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.66500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 39.66500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE ACE-TYR-VAL-ALA-ASP-CHLOROMETHYLKETONE IS PEPTIDE-LIKE, A REMARK 400 MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: ACE-TYR-VAL-ALA-ASP-CHLOROMETHYLKETONE REMARK 400 CHAIN: C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 72 28.93 83.32 REMARK 500 ASN A 91 48.28 32.80 REMARK 500 SNN A 147 -141.19 168.76 REMARK 500 ASN A 158 -89.46 -116.14 REMARK 500 REMARK 500 REMARK: NULL DBREF 5LU9 C 300 305 PDB 5LU9 5LU9 300 305 DBREF 5LU9 A 26 288 UNP Q99538 LGMN_HUMAN 26 288 SEQADV 5LU9 GLN A 263 UNP Q99538 ASN 263 ENGINEERED MUTATION SEQRES 1 C 6 ACE TYR VAL ALA ASP 0QE SEQRES 1 A 263 GLY GLY LYS HIS TRP VAL VAL ILE VAL ALA GLY SER ASN SEQRES 2 A 263 GLY TRP TYR ASN TYR ARG HIS GLN ALA ASP ALA CYS HIS SEQRES 3 A 263 ALA TYR GLN ILE ILE HIS ARG ASN GLY ILE PRO ASP GLU SEQRES 4 A 263 GLN ILE VAL VAL MET MET TYR ASP ASP ILE ALA TYR SER SEQRES 5 A 263 GLU ASP ASN PRO THR PRO GLY ILE VAL ILE ASN ARG PRO SEQRES 6 A 263 ASN GLY THR ASP VAL TYR GLN GLY VAL PRO LYS ASP TYR SEQRES 7 A 263 THR GLY GLU ASP VAL THR PRO GLN ASN PHE LEU ALA VAL SEQRES 8 A 263 LEU ARG GLY ASP ALA GLU ALA VAL LYS GLY ILE GLY SER SEQRES 9 A 263 GLY LYS VAL LEU LYS SER GLY PRO GLN ASP HIS VAL PHE SEQRES 10 A 263 ILE TYR PHE THR SNN HIS GLY SER THR GLY ILE LEU VAL SEQRES 11 A 263 PHE PRO ASN GLU ASP LEU HIS VAL LYS ASP LEU ASN GLU SEQRES 12 A 263 THR ILE HIS TYR MET TYR LYS HIS LYS MET TYR ARG LYS SEQRES 13 A 263 MET VAL PHE TYR ILE GLU ALA CYS GLU SER GLY SER MET SEQRES 14 A 263 MET ASN HIS LEU PRO ASP ASN ILE ASN VAL TYR ALA THR SEQRES 15 A 263 THR ALA ALA ASN PRO ARG GLU SER SER TYR ALA CYS TYR SEQRES 16 A 263 TYR ASP GLU LYS ARG SER THR TYR LEU GLY ASP TRP TYR SEQRES 17 A 263 SER VAL ASN TRP MET GLU ASP SER ASP VAL GLU ASP LEU SEQRES 18 A 263 THR LYS GLU THR LEU HIS LYS GLN TYR HIS LEU VAL LYS SEQRES 19 A 263 SER HIS THR GLN THR SER HIS VAL MET GLN TYR GLY ASN SEQRES 20 A 263 LYS THR ILE SER THR MET LYS VAL MET GLN PHE GLN GLY SEQRES 21 A 263 MET LYS ARG MODRES 5LU9 SNN A 147 ASP MODIFIED RESIDUE HET ACE C 300 3 HET 0QE C 305 1 HET SNN A 147 7 HET NAG A 301 14 HET NAG A 302 14 HET SO4 A 303 5 HET SO4 A 304 5 HET 3Y7 A 305 16 HETNAM ACE ACETYL GROUP HETNAM 0QE CHLOROMETHANE HETNAM SNN L-3-AMINOSUCCINIMIDE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM SO4 SULFATE ION HETNAM 3Y7 7-(MORPHOLIN-4-YL)-2,1,3-BENZOXADIAZOL-4-AMINE HETSYN 0QE CHLORO METHYL GROUP HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 1 ACE C2 H4 O FORMUL 1 0QE C H3 CL FORMUL 2 SNN C4 H6 N2 O2 FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 5 SO4 2(O4 S 2-) FORMUL 7 3Y7 C10 H12 N4 O2 FORMUL 8 HOH *70(H2 O) HELIX 1 AA1 GLY A 39 TYR A 41 5 3 HELIX 2 AA2 ASN A 42 ASN A 59 1 18 HELIX 3 AA3 PRO A 62 GLU A 64 5 3 HELIX 4 AA4 THR A 104 VAL A 108 5 5 HELIX 5 AA5 THR A 109 GLY A 119 1 11 HELIX 6 AA6 ASP A 120 LYS A 125 5 6 HELIX 7 AA7 VAL A 163 HIS A 176 1 14 HELIX 8 AA8 GLU A 190 MET A 195 5 6 HELIX 9 AA9 TRP A 232 GLU A 244 1 13 HELIX 10 AB1 THR A 250 THR A 262 1 13 HELIX 11 AB2 LYS A 273 LYS A 279 5 7 HELIX 12 AB3 VAL A 280 GLY A 285 1 6 SHEET 1 AA1 6 ILE A 66 MET A 69 0 SHEET 2 AA1 6 HIS A 29 ALA A 35 1 N ILE A 33 O MET A 69 SHEET 3 AA1 6 HIS A 140 THR A 146 1 O HIS A 140 N TRP A 30 SHEET 4 AA1 6 LYS A 181 ILE A 186 1 O VAL A 183 N ILE A 143 SHEET 5 AA1 6 VAL A 204 THR A 208 1 O TYR A 205 N MET A 182 SHEET 6 AA1 6 MET A 268 GLY A 271 -1 O TYR A 270 N ALA A 206 SHEET 1 AA2 3 GLY A 149 SER A 150 0 SHEET 2 AA2 3 ILE A 153 VAL A 155 -1 O ILE A 153 N SER A 150 SHEET 3 AA2 3 ASP A 160 HIS A 162 -1 O LEU A 161 N LEU A 154 SHEET 1 AA3 2 ALA A 218 ASP A 222 0 SHEET 2 AA3 2 THR A 227 ASP A 231 -1 O LEU A 229 N TYR A 220 LINK C ACE C 300 N TYR C 301 1555 1555 1.38 LINK C ASP C 304 C1 0QE C 305 1555 1555 1.46 LINK C1 0QE C 305 SG CYS A 189 1555 1555 1.62 LINK C THR A 146 N SNN A 147 1555 1555 1.37 LINK C SNN A 147 N HIS A 148 1555 1555 1.27 LINK C5 SNN A 147 N HIS A 148 1555 1555 1.32 LINK ND2 ASN A 167 C1 NAG A 301 1555 1555 1.45 LINK ND2 ASN A 272 C1 NAG A 302 1555 1555 1.45 CRYST1 64.390 64.390 79.330 90.00 90.00 90.00 P 42 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015530 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015530 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012606 0.00000 HETATM 1 C ACE C 300 22.631 -23.333 -5.887 1.00 51.40 C HETATM 2 O ACE C 300 23.125 -22.633 -6.770 1.00 55.89 O HETATM 3 CH3 ACE C 300 21.474 -22.666 -5.142 1.00 50.47 C